Regulus Hit As Partner Sanofi Pulls Plug On Kidney Drug Study

Rare Kidney Diseases Proving Difficult For Both Companies

 
• By Andrew McConaghie
  
Sanofi
Sanofi is to halt development against Alport syndrome, but will consider other potential targets. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip